AzTrials
AzTrials

Pain, PostoperativePhase 2NCT04133051

Perioperative Analgesic Efficiency of Quadratus Lumborum Block vs Epidural in Radical Cystectomy

A Phase 2 study testing Quadratus Lumborum Block Using Bupivacaine 0.2% and Epidural Analgesia Using Bupivacaine 0.25% in people with Pain, Postoperative, run by National Cancer Institute, Egypt at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is performed to measure the perioperative analgesic efficiency of bilateral quadratus lumborum block versus epidural analgesia in bladder cancer patients undergoing radical cystectomy Read more about this study

Who is it for?
Ages 18 to 100 years
Conditions the study is for
Pain, Postoperative
What is being tested?
Quadratus Lumborum Block Using Bupivacaine 0.2% and Epidural Analgesia Using Bupivacaine 0.25%
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteEgypt
Study dates
15 Nov 2018to 15 Sep 2020
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ASA II-III
  • Adult patients (>18 years old)
  • Both sexes
  • Scheduled for radical cystectomy at NCI, CU

Who cannot join

  • Patient's refusal of the study procedures
  • Allergy to drugs used in the study
  • Patients with chronic pain
  • Patients with coagulopathies (INR > 1.6 or platelets count < 50,000 cc3)
  • Hemodynamically unstable patients (e.g. BP < 90/60)
  • Patients with local or intra-abdominal infections concerning intervention sites and septic patients

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • National Cancer Institute - Cairo University

    Cairo, 11796

Other trials in Egypt

About this study

Official title: Perioperative Analgesic Efficiency of Ultrasound Guided Quadratus Lumborum Block Versus Epidural Analgesia in Bladder Cancer Patients Undergoing Radical Cystectomy

This study is performed to measure the perioperative analgesic efficiency of bilateral quadratus lumborum block versus epidural analgesia in bladder cancer patients undergoing radical cystectomy

Read the detailed description
  1. Background and rationale: Bladder cancer is the ninth most common cancer in the world while being considerably common in both developed and developing countries. Bladder cancer is the most common malignancy among Egyptian males and it had been previously attributed to Schistosoma infection, a major risk factor for squamous cell carcinoma (SCC). Recently, transitional cell carcinoma (TCC) incidence has been increasing while SCC has declined. Exposures to tobacco smoke, occupational toxins, and environmental sources of heavy metals such as arsenic are the major reported risk factors for TCC . Acute perioperative pain management has been a matter of attention especially in major abdominal surgeries like radical cystectomy. Poor perioperative pain management especially with major abdominal surgeries can lead to deterioration of both physiological and psychological status of the patient leading to anxiety, stress, and patient's dissatisfaction while also leading to severe abdominal pain and diminished respiratory functions due to impaired function of accessory respiratory muscles which may precipitate shallow breathing, atelectasis, retained secretions, and also lack of patient's cooperation. Adequate multimodal perioperative pain management improves patient's recovery and survival on a general prospective due to decreased surgical stress response leading to better immunological functions and coagulation profile, and hence improving the outcome of the surgery. Perioperative epidural analgesia has been associated with improved overall survival but not reduced cancer recurrence. However, patients receiving epidural analgesia with or without general anesthesia have shown longer survival over 5 years period postoperatively than those receiving general anesthesia alone which can be related to better immunological profile and decreased stress response in regional anesthesia group of patients. Epidural analgesia for perioperative pain management has proven earlier recovery in post anesthesia care unit (PACU) with better pain and respiratory tolerance and decreased need for intravenous opioid administration. Perioperative continuous epidural analgesia was found to reduce hospital stay for patients undergoing major abdominal surgeries. Quadratus lumborum (QL) block was first described by Blanco and was previously called (the posterior approach of TAP block). Volunteers for QL spread of local anesthetic have shown a good spread of local anesthetics from T4 to L1 proving adequacy of QL block for analgesia over both posterior and anterior abdominal region surgeries. Further studies are being made to assess the adequacy of QL block as an analgesic technique for major abdominal surgeries. Perioperative analgesia using QL block with the ipsilateral technique following minor abdominal surgeries has shown decreased need for intravenous administration of opioids and has also shown promising results for adequate perioperative analgesia after major abdominal surgeries. Many reports have suggested that QL block can provide adequate analgesia not only for abdominal wall somatic pain but for severe visceral pain as well. The mechanism for visceral pain analgesia is not fully understood but it is suggested to be due to paravertebral spread of the injected local anesthetic. Early post-operative ambulation of bladder cancer patients undergoing radical cystectomy can be achieved using QL block which have a positive impact on both surgical outcome and patient survival. Radical cystectomy patients receiving QL block have shown decreased hospital stay with earlier discharge due to adequate long lasting analgesia and early ambulation.
  2. Objectives: Primary Outcome: To test feasibility, efficiency, and safety of continuous perioperative QL block for perioperative pain management in bladder cancer patients undergoing radical cystectomy in comparison to continuous perioperative epidural analgesia for the same surgical procedure.
  3. Study Design:
  • This study will be Prospective Randomized Controlled Study.
  • The study will be submitted to the Institutional Review Board (IRB) for review.
  1. List of Correlative Studies:
  • Blanco R, Ansari T, Girgis E (2015): Quadratus lumborum block for postoperative pain after caesarean section: a randomised controlled trial. European Journal of Anaesthesiology (EJA). 32(11):812-8.
  • Blanco R, Ansari T, Riad W, \& Shetty N (2016). Quadratus lumborum block versus transversus abdominis plane block for postoperative pain after cesarean delivery: a randomized controlled trial. Regional anesthesia and pain medicine, 41(6), 757-762.
  1. Study Methods:
  • Interventions: Pre-interventional preparation:
  • Sedation for all patients prior to analgesic procedure at preoperative preparatory room using midazolam (0.02 mg/kg) intravenously.
  • Patients will be re-instructed about our anesthetic procedure steps according to each group.
  • Standard ASA monitoring for all patients before and during the anesthetic procedure.
  • Anesthetic procedure will start at the preoperative preparatory room in the form of regional block according to each of the study groups with catheter insertion and assessment of procedure success as discussed later.
  • Patients will be subjected to either quadratus lumborum block or epidural catheter insertion and analgesia as described later on.
  • Success of catheter insertion will be evaluated using 5ml of lidocaine 5% per catheter injection before proceeding with regular anesthetic doses. Analgesia level of T4 will be satisfactory for permitting transfer of patients to OR to proceed with general anesthesia and surgical procedure.
  • Routine assessment of all patients including assessment of patient's medical history, clinical examination, laboratory investigations (kidney and liver functions, CBC, and coagulation profile), ECG will be conducted on all patients above 40 years old and echocardiography for patients with suspected cardiomyopathies by medical history or preoperative examination. Chest X-ray for all patients suspected for respiratory diseases.
  • Patients will be subjected to continuous monitoring during surgery for any further complications related to anesthetic techniques and to surgery itself.
  • Patients will be monitored at PACU post-operatively to ensure hemodynamic stability, adequate analgesia, and attention for any possible complications that may occur due to anesthetic or surgical techniques used.
  • Patients will be discharged using the modified Aldrete's scoring system, a score of 9 or more will be sufficient for safe discharge of the patient to ward for further monitoring, continuation of analgesic techniques, and assessment of adequacy of analgesia post-operatively.
  • Patients' discharge time till reaching sufficient Aldrete's score for each study group will be calculated and included in the study parameters for further assessment of safety and efficiency of analgesic techniques used.
  • Possible risks:
  • Orthostatic hypotension.
  • Hemodynamic instability (e.g. bradycardia, ECG changes, tachycardia).
  • Local anesthetic toxicity.
  • Source of Funding: No source of funding.
  • Time plan:
  • The study is to be started in 2018 and is expected to be finished in 2020.
  • The expected publishing date is 2020.
  • Benefits from the study: To test feasibility, efficiency, and safety of continuous perioperative QL block for perioperative pain management in bladder cancer patients undergoing radical cystectomy in comparison to continuous perioperative epidural analgesia for the same surgical procedure.
  • Possible Risk:
  • Orthostatic hypotension.
  • Hemodynamic instability (e.g. bradycardia, ECG changes, tachycardia).
  • Local anesthetic toxicity.
  1. Protection of privacy and confidentiality of patients' information: Data collection and presentation will be anonymous and both privacy and confidentiality will be protected to the maximal possible standards.
  2. Publication policy:

Any article arising from this work will carry the names of all participants with the name orders according to the degree of contribution to data interpretation and manuscript writing. Additional external authors may be added if they add to the content and qualify for authorship by the international standards.

Being tested
Quadratus Lumborum Block Using Bupivacaine 0.2%, Epidural Analgesia Using Bupivacaine 0.25%
Keywords
quadratus lumborum block, epidural analgesia, bladder cancer, radical cystectomy
Medical subject headings
Pain, Postoperative, Urinary Bladder Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Quadratus Lumborum Block Using Bupivacaine 0.2%Drug

    Also called Transmuscular QL

    Ultrasound guided transmuscular approach for quadratus lumborum block using an 18 gauge Touhy's epidural needle to insert the catheter. Normal saline 5 mL will be used to identify that plane. A volume of 20 ml of 0.25% of Bupivacaine bolus will be injected in that plane just over QL. This will be followed by epidural catheter insertion to facilitate continuous infusion. A similar procedure will be performed on the other side. A continuous infusion of 0.2% Bupivacaine at 5 ml/h will be administered to the patient.

    This transmuscular quadratus lumborum (TQL) block, has been suggested to be a simple and perhaps safer alternative to the anterior approach as was described for the original QL block

  • Epidural Analgesia Using Bupivacaine 0.25%Drug

    Also called Thoracic Epidural

    With Patients placed in sitting position, puncture site will be identified at (T8-9, T9-10, or T10-11) intervertebral spaces. Using aseptic conditions, an 18G Tuohy epidural needle will be used to insert epidural catheter as appropriate.

    Induction of epidural analgesia with 10-15 ml bupivacaine 0.25% preoperatively with top up doses of 5-7 ml bupivacaine 0.25% or equivalent administered judiciously till we achieve analgesic level of T4 to L1. The calculated top up doses will be administered each hour using bupivacaine 0.25% or by using a continuous infusion syringe pump for equivalent doses

Study groups in NCT04133051
Study groupRoleWhat they receive
Quadratus Lumborum BlockActive comparator17 cases will be subjected to bilateral Ultrasound-guided Quadratus lumborum block through bilateral catheter insertion for perioperative analgesia.
Receives: Drug: Quadratus Lumborum Block Using Bupivacaine 0.2%
Epidural AnalgesiaActive comparator17 cases will be subjected to epidural catheter insertion for perioperative analgesia (as a control group).
Receives: Drug: Epidural Analgesia Using Bupivacaine 0.25%

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual analogue pain (VAS) score measurement postoperatively

    The primary outcome measures visual analogue pain scores in the two groups at the end of surgery

    Measured: 0 Hours Postoperatively

  2. Visual analogue pain (VAS) score measurement 6 hours postoperatively

    The primary outcome measures visual analogue pain scores in the two groups 6 hours postoperatively

    Measured: 6 Hours Postoperatively

  3. Visual analogue pain (VAS) score measurement 24 hours postoperatively

    The primary outcome measures visual analogue pain scores in the two groups 24 hours postoperatively

    Measured: 24 Hours Postoperatively

  4. Visual analogue pain (VAS) score measurement 48 hours postoperatively

    The primary outcome measures visual analogue pain scores in the two groups 48 hours postoperatively

    Measured: 48 Hours Postoperatively

Secondary outcomes (1)
  1. Postoperative Nausea and Vomiting

    Postoperative Nausea and Vomiting using nausea score (0 for none, 1 for mild to moderate nausea, 2 for moderate nausea, 3 for severe nausea accompanied by vomiting) When patient's nausea score reaches ≥ 2; intravenous anti-emetics in the form of Ondasetron 8mg and will be administered and recorded in all groups

    Measured: 48 Hours Postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Oct 2019
  2. Study start15 Nov 2018
  3. Primary completion15 Sep 2020
  4. Study completion15 Sep 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Group (A): 17 cases will be subjected to bilateral Ultrasound-guided Quadratus lumborum block through bilateral catheter insertion for perioperative analgesia. Group (B): 17 cases will be subjected to epidural catheter insertion for perioperative analgesia (as a control group). This number is to be increased to 34 patients (17 patients in each group) to account for the necessity to use non-parametric test. Sample size was calculated using G\*Power program (University of Düsseldorf, Düsseldorf, Germany) 17, 20, 21.
Masking
None (open label)
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04133051
Sponsor's protocol ID
AP1811-30103
Status last verified
Sep 2020
First submitted
12 Aug 2019
Last updated
25 Sep 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Blanco R, Ansari T, Girgis E. Quadratus lumborum block for postoperative pain after caesarean section: A randomised controlled trial. Eur J Anaesthesiol. 2015 Nov;32(11):812-8. doi: 10.1097/EJA.0000000000000299.

    PubMed 26225500
  • Blanco R, Ansari T, Riad W, Shetty N. Quadratus Lumborum Block Versus Transversus Abdominis Plane Block for Postoperative Pain After Cesarean Delivery: A Randomized Controlled Trial. Reg Anesth Pain Med. 2016 Nov/Dec;41(6):757-762. doi: 10.1097/AAP.0000000000000495.

    PubMed 27755488

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Quadratus Lumborum Block Using Bupivacaine 0.2% and Epidural Analgesia Using Bupivacaine 0.25% in people with Pain, Postoperative, run by National Cancer Institute, Egypt at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual analogue pain (VAS) score measurement postoperatively (time frame: 0 Hours Postoperatively). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04133051, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in